期刊文献+

乳腺肿块超声造影定量分析研究 被引量:1

Quantitative analysis of contrast-enhanced ultrasound in breast lesions
下载PDF
导出
摘要 目的探讨超声造影定量评估乳腺肿块的可行性和稳定性。方法通过重复分析良恶性乳腺肿块超声造影图像的定量参数,研究取3次数据的中位数、最相近两次数据的平均值及3次数据的平均值这3种方法所得数据与病理结果间的差异。结果 151个乳腺肿块中,3种数据处理方法显示良恶性肿块的峰值P值均为0.000,曲线下面积(AUC)的P值分别为0.002、0.004、0.004。选择评判标准时,中位数法以AUC<3.850时诊断恶性肿块的灵敏度80.7%、特异度为61.9%,三者均值法以峰值<25.000时诊断恶性肿块的灵敏度为79.8%、特异度为71.4%,为最佳选择。结论应用超声造影定量分析评估乳腺肿块可行,重复分析,取中位数或平均值的方法均可减少数据偏差。 Objective To explore the feasibility and stability of contrast-enhanced ultrasound in quantitative assessment of breast lesions. Methods By repeating analysis of the quantitative parameters of contrast-enhanced ultrasound in benign and malignant breast lesions, the median of three sets of data, the mean of two closest sets of data and the mean of three sets of data were compared. Results In 151 breast tumors, three methods showed that there were significant differences in peak(all P=0.000) and area under curve(AUC)(P=0.002, 0.004 and 0.004, respectively) between benign and malignant breast lesions.When median AUC <3.850 was selected asthreshold, the sensitivity of diagnosis of malignant breast cancer was 80.7%, and the specificity was 61.9%. When mean peak of three sets of data <25.000 was selected as threshold, the sensitivity was79.8%, and the specificity was 71.4%. They were the best choices. Conclusion It's feasible to use quantitative analysis of contrast-enhanced ultrasound to evaluate the breast lesions. The median or mean can reduce data bias.
出处 《肿瘤影像学》 2013年第3期256-259,共4页 Oncoradiology
基金 上海市黄浦区卫生局重点专科课题(超声专科建设课题2)
关键词 乳腺肿块 超声造影 定量分析 Breast lesion Contrast-enhanced ultrasonography Quantitative analysis
  • 相关文献

参考文献10

二级参考文献33

  • 1徐金顺,朱才义.超声造影诊断肝脏局灶性病变的研究进展[J].中华医学超声杂志(电子版),2011,8(5):1116-1120. 被引量:8
  • 2步宏,郑杰.美国临床肿瘤学会/美国病理学医师学院乳腺癌HER2检测指南简介[J].中华病理学杂志,2007,36(7):496-497. 被引量:24
  • 3Shaked Y, Bertolini F, Man S, et al. Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell, 2005,7:101- 111.
  • 4Testa AC,Ferrandina G, Ferrandina E, et al. The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases. J Ultrasound Med,2005,249 : 1267-1278.
  • 5Tavassoli FA, Devilee P. World Health Organization classification of tumors. Pathlogy and gengtics, tumors of the breast and female genital organs. Lyon : IARC Press, 2003 : 10.
  • 6Salvucci O, Yao L, Villalba S, et al. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal derived factor 1. Blood, 2002,99 : 2703- 2711.
  • 7Kettenbach J, Hellbich TH, Huber S, et al. Computer-assisted quantitative assessment of power Doppler US: effeets of mierobubble contrast agent in the differentiation of breast tumors. Eur J Radiol, 2005,53 : 238-244.
  • 8Mie Lee Y, Kim SH, Kim HS, et al. Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppressin of HIF-lalpba activity. Biochem Biophys Res Common, 2003,300 : 241-246.
  • 9Cianfrocca M,Goldstein LJ.Prognostic and predictive factors in early-stage breast cancer.Oncologist,2004,9:606-616.
  • 10Stuhrmann M,Aronius R,Schietzel M.Tumor vascularity of breast lesions:potentials and limits of contrast-enhanced Doppler sonography.Am J Roentgenol,2000,175:1585-1589.

共引文献57

同被引文献16

  • 1Uematsu T. Uhrasonographie findings of missed breast cancer: pitfalls and pearls[J]. Breast Cancer, 2014, 21(1) : 10-19.
  • 2Boghaert E, Radisky DC, Nelson CM. Lattice-based model of ductal carcinoma in situ suggests rules for breast cancer progres- sion to an invasive state[J/CD]. PLoS Comput Biol, 2014, 10(12) :e1003997.
  • 3Piscaglia F, Nolsoe C, Dietrich CF, et al. The EFSUMB Guide- lines and Recommendations on Clinical Practice of Contrast En- hanced Ultrasound (CEUS):Update 2011 on non-hepatic appli cation[J]. Ultraschall Med, 2012, 33 ( 1 ) : 33-39.
  • 4Wang L, Du J, Li FH, et al. Diagnostic efficacy of contrast-en- hanced sonography by combined qualitative and quantitative a- nalysis in breast lesions:a comparative study with magnetic reso nance imaging[J]. J Ultrasound Med, 2013,32(10) : 1805- 1814.
  • 5Dietzel M, Baltzer PA, Vag T,et al. The adjacent vessel sign on breast MRI:new data and a subgroup analysis for 1,084 histo- logically verified cases[J]. Korean J Radiol, 2010,11 (2) : 178 -186.
  • 6Yang WT, Tse GM, Lam PK, et al. Correlation between color power Doppler sonographic measurement of breast tumor vascu- lature and immunohistochemical analysis of mierovessel density for the quantitation of angiogenesis[J]. J Ultrasound Med, 2002,21(11) :1227-1235.
  • 7Tamaki K, Sasano H, Ishida T, et al. The correlation between ultrasonographic findings and pathologic features in breast disor- ders[J]. Jion J Clin Oneol,2010,40(10) 1905-912.
  • 8Irshad A, Leddy R,Pisano E, et al. Assessing the role of ultra- sound in predicting the biological behavior of breast cancer[J].AJR Am J Roentgenol,2013,200(2) :284-290.
  • 9Jiang J,Chen YQ, Xu YZ, et al. Correlation between three-di- mensional ultrasound features and pathological prognostic factors in breast cancer[J]. Eur Radiol, 2014,24(4) : 1186-1196.
  • 10Wang XY, Kang LK, Lan CY. Contrast-enhanced ultrasonogra- phy in diagnosis of benign and malignant breast [J]. EJGO, 2014,35(4) :415 -420.

引证文献1

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部